TGIF1 and neoplasm: In support of our hypothesis, immunofluorescence staining and confocal microscopy revealed that 5 days after breast cancer cell injection, the presence of tumor cells in the bone marrow microenvironment was reduced by 25% in Tgif1−/− mice compared to Tgif1+/+ mice (Fig. 2b).